| Revision as of 00:14, 21 September 2018 editAdhiyana (talk | contribs)Extended confirmed users771 edits →Research: Fixed grammarTags: Mobile edit Mobile app edit Android app edit← Previous edit | Revision as of 00:23, 21 September 2018 edit undoAdhiyana (talk | contribs)Extended confirmed users771 edits →Research: Citations are of systematic reviews not individual trials. Conclude further study is necessary, do not establish that they are ineffective.Tags: Mobile edit Mobile app edit Android app editNext edit → | ||
| Line 19: | Line 19: | ||
| == Research == | == Research == | ||
| As of 2018, there had been several |
As of 2018, there had been several systematic reviews of psychobiotic clinical trials which concluded there is currently insufficient evidence that psychobiotics are effective in humans.<ref>{{cite journal | vauthors = Romijn AR, Rucklidge JJ | title = Systematic review of evidence to support the theory of psychobiotics | journal = Nutrition Reviews | volume = 73 | issue = 10 | pages = 675–93 | date = October 2015 | pmid = 26370263 | doi = 10.1093/nutrit/nuv025 | url = https://academic.oup.com/nutritionreviews/article/73/10/675/1848054 }}</ref><ref>{{cite journal | vauthors = Liu B, He Y, Wang M, Liu J, Ju Y, Zhang Y, Liu T, Li L, Li Q | title = Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials | journal = Depression and Anxiety | date = July 2018 | pmid = 29995348 | doi = 10.1002/da.22811 }}</ref> | ||
| Preclinical trials include studies in ] such as rats and mice. ] demonstrate heightened physiological reactions to psychological stress compared to animals with a normal microbiome, and that these phenomena were reversible by promoting the formation of a healthy microbiome using probiotic treatment.<ref name=":0" /> Psychobiotic treatment of mice exposed to a ] model of anxiety and depression has been found to prevent the fall in physical performance and raised pro-inflammatory ] levels associated with untreated mice, and treatment of mice with ] probiotics has been found to reduce activation of the ] and colonic dysfunction in similar circumstances. These mice also expressed fewer depressive and anxious behaviours.<ref name=":0" /> In a similar maternal stress model the psychobiotic species ] was able to reduce corticosterone markers of increased HPA axis activity in mice.<ref name=":6">{{cite journal | vauthors = Liu YW, Liong MT, Tsai YC | title = New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis | journal = Journal of Microbiology | volume = 56 | issue = 9 | pages = 601–613 | date = September 2018 | pmid = 30141154 | doi = 10.1007/s12275-018-8079-2 }}</ref> | Preclinical trials include studies in ] such as rats and mice. ] demonstrate heightened physiological reactions to psychological stress compared to animals with a normal microbiome, and that these phenomena were reversible by promoting the formation of a healthy microbiome using probiotic treatment.<ref name=":0" /> Psychobiotic treatment of mice exposed to a ] model of anxiety and depression has been found to prevent the fall in physical performance and raised pro-inflammatory ] levels associated with untreated mice, and treatment of mice with ] probiotics has been found to reduce activation of the ] and colonic dysfunction in similar circumstances. These mice also expressed fewer depressive and anxious behaviours.<ref name=":0" /> In a similar maternal stress model the psychobiotic species ] was able to reduce corticosterone markers of increased HPA axis activity in mice.<ref name=":6">{{cite journal | vauthors = Liu YW, Liong MT, Tsai YC | title = New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis | journal = Journal of Microbiology | volume = 56 | issue = 9 | pages = 601–613 | date = September 2018 | pmid = 30141154 | doi = 10.1007/s12275-018-8079-2 }}</ref> | ||
Revision as of 00:23, 21 September 2018
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Psychobiotics are probiotic or prebiotic substances which are intended to confer mental health benefits by assisting or causing colonisation of the gut with commensal bacteria, which is hypothesized to modify brain function via the gut–brain axis.
Types
In probiotic psychobiotics the bacteria most commonly used are Gram-positive bacteria such as the Bifidobacterium and Lactobacillus families, as these do not contain pro-inflammatory lipopolysaccharide chains, reducing the likelihood of an immunological response.
Prebiotic psychobiotics are substances such as fructans and oligosaccharides, which promote the growth of intrinsic commensal bacteria by their fermentation in the gut.
A combination of a prebiotic and a probiotic is known as a synbiotic. Multiple bacterial species contained in a single probiotic broth is known as a polybiotic.
Proposed mechanisms of action
Pathological changes in gut microbiotia may activate pro-inflammatory pathways via the NALP3 inflammasome which has been identified as a potential trigger for major depressive disorder.
The brain-gut axis and tryptophan metabolism have been linked. The brain cannot store tryptophan and requires a constant supply of this substance. Reduced peripheral tryptophan levels have been associated with depressive phenotype, and tryptophan levels and availability have been found to be directly influenced by the gut microbiota with Bifidobacteria being show to increase peripheral tryptophan. Bacteria play a role in serotonin synthesis from tryptophan in the gut Enterochromaffin cells and germ-free mice which are treated with probiotics show threefold increases in serotonin production.
Some intestinal microbes have been found to produce psychotropic effects by secreting neurotransmitter and neurotransmitter precursor molecules such as GABA, glycine, catecholamines and tyrosine, and also by regulating endocannabinoid receptor expression.
Research
As of 2018, there had been several systematic reviews of psychobiotic clinical trials which concluded there is currently insufficient evidence that psychobiotics are effective in humans.
Preclinical trials include studies in animal models such as rats and mice. Mice raised in a sterile environment demonstrate heightened physiological reactions to psychological stress compared to animals with a normal microbiome, and that these phenomena were reversible by promoting the formation of a healthy microbiome using probiotic treatment. Psychobiotic treatment of mice exposed to a maternal deprivation model of anxiety and depression has been found to prevent the fall in physical performance and raised pro-inflammatory cytokine levels associated with untreated mice, and treatment of mice with Lactobacillus rhamnosus probiotics has been found to reduce activation of the Hypothalamic–pituitary–adrenal axis and colonic dysfunction in similar circumstances. These mice also expressed fewer depressive and anxious behaviours. In a similar maternal stress model the psychobiotic species Lactobacillus plantarum was able to reduce corticosterone markers of increased HPA axis activity in mice.
Bimuno-GOS and FOS prebiotic supplementation has been found to have neuroprotective activity in animal models, and to raise BDNF levels in the hippocampus. Short chain fatty acids such as butyrate, acetate and propionate are produced in increased amounts following administration of prebiotics in animal models. Butyrate has been demonstrated to have antidepressant effects, can cross the Blood–brain barrier, and has neuroprotective activity. This is thought to be mediated via its role as an epigenetic modulator, acting as a Histone deacetylase inhibitor. SCFAs also affect the local gut mucosal immune system, a potential mechanism by which modulation of the HPA axis may occur.
An association between adopting a Mediterranean diet and a reduction in depression has been well established, with even moderate adherence reducing depression risk, whilst more "western", high-fat, sugar diets are associated with higher reported anxiety and depression in women. It has been suggested that microbiota analysis of those on Mediterranean diets may help identify bacterial strains with potental psychobiotic activity.
Species
_Lactobacillus_acidophilus_(D%C3%B6derlein_bacillus).jpg)
Several species of bacteria have been used in probiotic psychobiotic preparations:
- Lactobacillus helveticus
- Bifidobacterium longum
- Lactobacillus casei
- Lactobacillus plantarum
- Lactobacillus acidophilus
- Lactobacillus delbrueckii subsp. bulgaricus
- Bifidobacterium breve
- Bifidobacterium infantis
- Streptococcus salivarius
References
- ^ Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW (November 2016). "Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals". Trends in Neurosciences. 39 (11): 763–781. doi:10.1016/j.tins.2016.09.002. PMC 5102282. PMID 27793434.
- ^ Bambury A, Sandhu K, Cryan JF, Dinan TG (December 2017). "Finding the needle in the haystack: systematic identification of psychobiotics". British Journal of Pharmacology. doi:10.1111/bph.14127. PMID 29243233.
- Inserra A, Rogers GB, Licinio J, Wong ML (September 2018). "The Microbiota-Inflammasome Hypothesis of Major Depression". BioEssays. 40 (9): e1800027. doi:10.1002/bies.201800027. PMID 30004130.
- Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C (2014). "Bacterial neuroactive compounds produced by psychobiotics". Advances in Experimental Medicine and Biology. 817: 221–39. doi:10.1007/978-1-4939-0897-4_10. PMID 24997036.
- Romijn AR, Rucklidge JJ (October 2015). "Systematic review of evidence to support the theory of psychobiotics". Nutrition Reviews. 73 (10): 675–93. doi:10.1093/nutrit/nuv025. PMID 26370263.
- Liu B, He Y, Wang M, Liu J, Ju Y, Zhang Y, Liu T, Li L, Li Q (July 2018). "Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials". Depression and Anxiety. doi:10.1002/da.22811. PMID 29995348.
- ^ Liu YW, Liong MT, Tsai YC (September 2018). "New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis". Journal of Microbiology. 56 (9): 601–613. doi:10.1007/s12275-018-8079-2. PMID 30141154.